| Covidomic: A Multi-Modal Cloud-Based Platform For Identification Of Risk Factors Associated With Covid-19 Severity | 0 | 0.34 | 2021 |
| Drugcentral 2021 Supports Drug Discovery And Repositioning | 1 | 0.34 | 2021 |
| Tcrd And Pharos 2021: Mining The Human Proteome For Disease Biology | 0 | 0.34 | 2021 |
| TIGA: target illumination GWAS analytics | 0 | 0.34 | 2021 |
| Off-Patent Drug Repositioning | 0 | 0.34 | 2020 |
| SmartGraph: a network pharmacology investigation platform. | 0 | 0.34 | 2020 |
| DrugCentral 2018: an update. | 0 | 0.34 | 2019 |
| Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records. | 0 | 0.34 | 2018 |
| Leaving us with fond memories, smiles, SMILES and, alas, tears: a tribute to David Weininger, 1952–2016 | 0 | 0.34 | 2018 |
| Formalizing drug indications on the road to therapeutic intent. | 1 | 0.41 | 2017 |
| DrugCentral: online drug compendium. | 16 | 0.77 | 2017 |
| Obituary: Toshio Fujita, QSAR pioneer. | 0 | 0.34 | 2017 |
| Drug target ontology to classify and integrate drug discovery data. | 1 | 0.36 | 2017 |
| Pharos: Collating Protein Information To Shed Light On The Druggable Genome | 10 | 0.71 | 2017 |
| Protein biomarker druggability profiling. | 0 | 0.34 | 2017 |
| Learning Reference-Enriched Approach Towards Large Scale Active Ontology Alignment And Integration | 0 | 0.34 | 2017 |
| The Ontology Reference Model For Visual Selectivity Analysis In Drug-Target Interactions | 0 | 0.34 | 2017 |
| TIN-X: target importance and novelty explorer. | 1 | 0.35 | 2017 |
| Badapple: promiscuity patterns from noisy evidence. | 3 | 0.79 | 2016 |
| Impact of similarity threshold on the topology of molecular similarity networks and clustering outcomes. | 2 | 0.67 | 2016 |
| ChemProt-3.0: a global chemical biology diseases mapping. | 8 | 0.46 | 2016 |
| Erratum to: Impact of similarity threshold on the topology of molecular similarity networks and clustering outcomes. | 0 | 0.34 | 2016 |
| Protein Drug Target Prioritization for Illumination. | 0 | 0.34 | 2015 |
| Genomic dark matter, druggability and misunderstood targets. | 0 | 0.34 | 2014 |
| A systems chemical biology study of malate synthase and isocitrate lyase inhibition in Mycobacterium tuberculosis during active and NRP growth. | 1 | 0.48 | 2013 |
| The CARLSBAD Database: A Confederated Database of Chemical Bioactivities. | 7 | 0.51 | 2013 |
| Chemprot-2.0: Visual Navigation In A Disease Chemical Biology Database | 14 | 0.83 | 2013 |
| Discovery of a Novel Selective PPARγ Ligand with Partial Agonist Binding Properties by Integrated / Work Flow. | 0 | 0.34 | 2013 |
| Of possible cheminformatics futures. | 1 | 0.38 | 2012 |
| Chemprot: A Disease Chemical Biology Database | 9 | 0.64 | 2011 |
| iPHACE: integrative navigation in pharmacological space. | 3 | 0.46 | 2010 |
| Model-Free Drug-Likeness from Fragments. | 2 | 0.40 | 2010 |
| Scaffold Topologies. 2. Analysis of Chemical Databases. | 2 | 0.49 | 2008 |
| Efficient Calculation of Molecular Properties from Simulation Using Kernel Molecular Dynamics. | 2 | 0.37 | 2008 |
| Quantifying the Relationships among Drug Classes. | 26 | 1.70 | 2008 |
| Scaffold Topologies. 1. Exhaustive Enumeration up to Eight Rings. | 7 | 0.63 | 2008 |
| Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? | 53 | 2.47 | 2008 |
| Lead-like, drug-like or "Pub-like": how different are they? | 2 | 0.40 | 2007 |
| Ligand-Based Virtual Screening by Novelty Detection with Self-Organizing Maps. | 7 | 0.50 | 2007 |
| Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios. | 4 | 0.52 | 2007 |
| MTD-PLS: A PLS Variant of the Minimal Topologic Difference Method. III. Mapping Interactions between Estradiol Derivatives and the Alpha Estrogenic Receptor. | 0 | 0.34 | 2005 |
| Descriptor collision and confusion: toward the design of descriptors to mask chemical structures. | 4 | 0.40 | 2005 |
| Surrogate data - a secure way to share corporate data. | 4 | 0.43 | 2005 |
| Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry. | 12 | 1.07 | 2005 |
| An automated PLS search for biologically relevant QSAR descriptors. | 13 | 1.18 | 2004 |
| Distant collaboration in drug discovery: the LINK3D project. | 3 | 0.95 | 2002 |
| MTD-PLS: A PLS-based variant of the MTD method. 2. Mapping ligand-receptor interactions. Enzymatic acetic acid esters hydrolysis. | 1 | 0.63 | 2002 |
| Current trends in lead discovery: Are we looking for the appropriate properties? | 16 | 3.53 | 2002 |
| Is There a Difference between Leads and Drugs? A Historical Perspective. | 43 | 8.19 | 2001 |
| Property distribution of drug-related chemical databases. | 63 | 6.22 | 2000 |
